HepaRegeniX GmbH
HepaRegeniX GmbH
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety of HRX215 in Patients After Minor and Major Liver Resection | Colorectal Carcinoma Liver Metastases; Liver Resection | Recruiting | Phase 1 / Phase 2 | 2026-09-14 | NCT06638502 |